Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 67.6 TWD Market Closed
Market Cap: 11.1B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Net Income (Common) Peer Comparison

Comparables:
688235
6550

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Net Income (Common)
-NT$1.8B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Net Income (Common)
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Net Income (Common)
-NT$1.6B
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Net Income (Common)?
Net Income (Common)
-1.8B TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Net Income (Common) amounts to -1.8B TWD.

What is Tanvex BioPharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%

Over the last year, the Net Income (Common) growth was 9%. The average annual Net Income (Common) growth rates for Tanvex BioPharma Inc have been -2% over the past three years , 2% over the past five years .

Back to Top